Source: google_news
Source ID: gnews:723bd26ad423a954e172fc4694cdbcfc:ARWR
URL: https://news.google.com/rss/articles/CBMixAFBVV95cUxNQUU0U1dETjV3ZnhmTUQzRm9TaW8wRC1EQ1JJNXJyM3NxVFVOSE4yaG80NkRTMW5mXzJ5Ny1PTnQ4cy1TUHFPUEZ1Wjk2aDhmV3M1TC1LbTkyeU1jTDBtWTluRU4tdDZHSnhWMjVucUxVdmxOODZTdG1xMmkyWUJuanluU0RjVC1CN3VpZjR5MUtjNHhKOVVHalRPTDdKZUJUOFV3Ri1qZ2s4VXFWSDVqYl8zNlVqb0E2M3pHQ1dfeDBtdnRf?oc=5
Symbol: (ARWR)
Published: 2026-09-15 03:00:00 EDT
Time precision: minute
Title: Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
Arrowhead Pharmaceuticals, Inc.